IRHOR Iron Horse latest quarterly earnings filing omits core financial metrics and formal forward guidance Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside Adaptive Bio ADPT Stock Market Risk 232 20260427